Low Incidence of Perioperative Chemotherapy for Stage III Bladder Cancer 1998 to 2003: A Report From the National Cancer Data Base Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Carcinoma, Transitional Cell
  • Chemotherapy, Adjuvant
  • Neoadjuvant Therapy
  • Urinary Bladder Neoplasms

abstract

  • Perioperative chemotherapy is underused in the management of surgically resectable stage III transitional cell carcinoma of the bladder. This finding may reflect a delay in implementing the results of recently reported randomized trials, a low incidence of referrals by urologists for chemotherapy and/or confidence in salvage chemotherapy as an equivalent alternative. Further followup will determine if this treatment pattern changes in the future.

publication date

  • August 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2007.03.101

PubMed ID

  • 17561135

Additional Document Info

start page

  • 451

end page

  • 4

volume

  • 178

number

  • 2